{"url_path":"/sec/mira/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1904286/0001493152-26-023005-index.html","accession_number":"0001493152-26-023005","cik":"0001904286","ticker":"MIRA","issuer_name":"MIRA PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1904286/0001493152-26-023005-index.html","primary_entity_key":"0001904286","primary_entity_name":"MIRA PHARMACEUTICALS, INC."},"word_count":76,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors.**\n\n \n\nFor a discussion of risk factors, please read *Item 1A, “Risk Factors”* in our Annual Report\non Form 10-K for the fiscal year ended December 31, 2025. Such risk factors continue to be relevant to an understanding of our business,\nfinancial condition and operating results. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes from\nthe risk factors reported in our 2025 Annual Report."}